Table 1 Patient backgrounds
| Ā | Combined-admin. group (nā=ā50) | No-hypnotic group (nā=ā60) | P |
|---|---|---|---|
Age | Ā | Ā | Ā |
ā74 or younger | 24 (48.0%) | 42 (70.0%) | 0.031a |
ā75 or older | 26 (52.0%) | 18 (30.0%) | Ā |
Gender | Ā | Ā | Ā |
āMale | 20 (40.0%) | 38 (63.3%) | 0.021a |
āFemale | 30 (60.0%) | 22 (36.7%) | Ā |
Operative procedure | Ā | Ā | Ā |
āHepatectomy | 20 (40.0%) | 27 (45.0%) | 0.373b |
āPancreatectomy | 19 (38.0%) | 25 (41.7%) | Ā |
āOthers | 11 (22.0%) | 8 (13.3%) | Ā |
Performance status | Ā | Ā | Ā |
ā0 | 32 (64.0%) | 36 (60.0%) | 0.698a |
ā1ā¤ | 18 (36.0%) | 24 (40.0%) | Ā |
History of alcohol intake | 31 (62.0%) | 41 (68.3%) | 0.548a |
Previous disease | Ā | Ā | Ā |
āHypertension | 24 (48.0%) | 32 (53.3%) | 0.702a |
āMental disorder | 8 (16.0%) | 1 (1.7%) | 0.011a |
Adjuvant remedy | Ā | Ā | Ā |
āOpioid | 0 (0.0%) | 2 (3.3%) | 0.500a |
āAntidopaminergic drug | 0 (0.0%) | 1 (1.7%) | 1.000a |
āH2 receptor antagonist | 25 (50%) | 29 (48.3%) | 1.000a |
āSteroid | 0 (0.0%) | 3 (5.0%) | 0.249a |